Impax Laboratories, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Stocks To Trade: SQ, IPXL, ALSN
Article By: Ryan Mallory
Thursday, February 22, 2018 3:44 AM EDT
Thursday's stock picks: Square, Impax Laboratories and Allison Transmission.
In this article: IPXL, ALSN, SQ
Read
Looking For Action? S&P 1500 Most Volatile Stocks - Wednesday, Oct. 25
Article By: Bespoke Investment Group
Wednesday, October 25, 2017 11:47 AM EDT
With overall market volatility near record lows, it shouldn’t come as a surprise that there is not a whole low of major volatility in individual stocks.
In this article: FINL, MDXG, IPXL, SPX
Read
Premarket Biotech Digest – ANTM May Increase Premium, IPXL Receives FDA Approval, ZTS Receives EC Nod
Article By: KKD Healthcare Analytics
Thursday, April 27, 2017 7:20 AM EDT
Impax Laboratories announced receiving the FDA approval for its its generic version of cholesterol drug Vytorin. Anthem said that its premium may increase by 20 percent or more pursuant to the loss of federal subsidies supporting Obamacare plans.
In this article: AZN, DDD, ALNY, IPXL, MNOV, UTHR, ZTS, ANTM, FLKS
Read
Endo Drops After FTC Sues Over 'Pay-to-delay' Deals
Article By: The Fly
Thursday, March 31, 2016 1:14 PM EDT
Shares of Endo Pharmaceutical fell in morning trading in New York after the Federal Trade Commission announced that it was suing the company for blocking generic versions of its Opana ER and Lidoderm.
In this article: ENDP Also: AGN, IPXL
Read
All Posts

Latest Tweets for $IPXL

No tweets yet!

PARTNER HEADLINES